| scholarly article | Q13442814 |
| P50 | author | Ronald Swanstrom | Q62641484 |
| P2093 | author name string | Ronald Swanstrom | |
| Celia A Schiffer | |||
| Charles W Carter | |||
| Sook-Kyung Lee | |||
| Amy Rogers | |||
| Nese Kurt Yilmaz | |||
| Marc Potempa | |||
| Ean Spielvogel | |||
| Ellen A Nalivaika | |||
| P2860 | cites work | Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates | Q24812175 |
| The choreography of HIV-1 proteolytic processing and virion assembly | Q27009643 | ||
| How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease | Q27626817 | ||
| Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease | Q27637329 | ||
| Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes | Q27638967 | ||
| Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein | Q27639039 | ||
| HIV-1 Protease-Substrate Coevolution in Nelfinavir Resistance | Q27683192 | ||
| Structure of the immature HIV-1 capsid in intact virus particles at 8.8 Å resolution | Q27696126 | ||
| Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1 | Q27702268 | ||
| On the size of the active site in proteases. I. Papain | Q27860826 | ||
| Specific covalent labeling of recombinant protein molecules inside live cells | Q28276029 | ||
| Sensitive, soluble chromogenic substrates for HIV-1 proteinase | Q28330954 | ||
| Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss | Q28474984 | ||
| Purification of recombinant HIV-1 protease. | Q54703812 | ||
| Crystal structure of a retroviral protease proves relationship to aspartic protease family | Q58039010 | ||
| Analysis of subsite preferences of HIV-1 proteinase using MA/CA junction peptides substituted at the P3-P1' positions | Q67981478 | ||
| Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease | Q69564852 | ||
| HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins | Q70219564 | ||
| Conformational stability and catalytic activity of HIV-1 protease are both enhanced at high salt concentration | Q71058497 | ||
| Rate-determining steps in HIV-1 protease catalysis. The hydrolysis of the most specific substrate | Q71833687 | ||
| Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication | Q73514585 | ||
| Drug-resistant HIV-1 proteases identify enzyme residues important for substrate selection and catalytic rate | Q77349901 | ||
| Implications for viral capsid assembly from crystal structures of HIV-1 Gag(1-278) and CA(N)(133-278) | Q80280623 | ||
| ??? | Q57904706 | ||
| Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells | Q30479297 | ||
| Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease | Q30850215 | ||
| Synthetic peptides as substrates and inhibitors of a retroviral protease | Q33580337 | ||
| The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation | Q33727091 | ||
| Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation. | Q33845445 | ||
| Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells | Q33845811 | ||
| Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins | Q34098983 | ||
| On the role of the SP1 domain in HIV-1 particle assembly: a molecular switch? | Q34164929 | ||
| Structural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 protease | Q34526179 | ||
| A sensitive assay using a native protein substrate for screening HIV-1 maturation inhibitors targeting the protease cleavage site between the matrix and capsid | Q34771244 | ||
| Imaging the biogenesis of individual HIV-1 virions in live cells | Q34781463 | ||
| Conformation and dynamics of the Gag polyprotein of the human immunodeficiency virus 1 studied by NMR spectroscopy. | Q35212464 | ||
| Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease | Q35921690 | ||
| Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1 | Q36098898 | ||
| Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha | Q36446606 | ||
| A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. | Q36899532 | ||
| Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site. | Q36933950 | ||
| Structure and assembly of immature HIV | Q37237053 | ||
| Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistance | Q37410823 | ||
| HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. | Q37447762 | ||
| HIV-1 assembly, budding, and maturation | Q38023864 | ||
| High-resolution structure of a retroviral capsid hexameric amino-terminal domain | Q39272732 | ||
| Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. | Q39579012 | ||
| The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. | Q40042979 | ||
| Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein | Q40059062 | ||
| Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly | Q41047831 | ||
| In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes | Q41258387 | ||
| Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism | Q41275889 | ||
| HIV-1 Protease and Substrate Coevolution Validates the Substrate Envelope As the Substrate Recognition Pattern. | Q42109902 | ||
| Peptide substrates and inhibitors of the HIV-1 protease | Q42195484 | ||
| A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle | Q42546287 | ||
| Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites | Q42702065 | ||
| Dynamics of preferential substrate recognition in HIV-1 protease: redefining the substrate envelope | Q42825525 | ||
| Kinetic and modeling studies of S3-S3' subsites of HIV proteinases | Q44403208 | ||
| Co-evolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate | Q44629818 | ||
| Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites | Q44968894 | ||
| Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases | Q45740412 | ||
| Sub-site preferences of the aspartic proteinase from the human immunodeficiency virus, HIV-1. | Q45850256 | ||
| A transient precursor of the HIV-1 protease. Isolation, characterization, and kinetics of maturation. | Q52202674 | ||
| Assembly and analysis of conical models for the HIV-1 core. | Q52228420 | ||
| Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid | Q54693321 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5182-5195 | |
| P577 | publication date | 2018-11-07 | |
| P1433 | published in | Journal of Molecular Biology | Q925779 |
| P1476 | title | HIV-1 Protease Uses Bi-Specific S2/S2' Subsites to Optimize Cleavage of Two Classes of Target Sites | |
| P478 | volume | 430 |
| Q92057075 | An n→π* Interaction in the Bound Substrate of Aspartic Proteases Replicates the Oxyanion Hole | cites work | P2860 |
Search more.